Shares of Evaxion Biotech A/S EVAX rose sharply in today's pre-market trading after the company applied for a patent for vaccines targeting Neisseria gonorrhoeae. Evaxion Biotech shares jumped 62% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback